These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38287911)

  • 1. Exploring the facilitators and barriers in opioid deprescribing for non-cancer pain treatment experienced by general practitioners: A qualitative study.
    de Kleijn L; Jansen-Groot Koerkamp EAW; van der Kooij I; Veen M; Rijkels-Otters HJBM; Koes BW; Chiarotto A
    Eur J Pain; 2024 Aug; 28(7):1101-1115. PubMed ID: 38287911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators to opioid deprescribing among Advanced Nurse Practitioners: A qualitative interview study.
    McCann C; McCauley CO; Harkin D
    J Adv Nurs; 2024 Jun; 80(6):2500-2511. PubMed ID: 38082475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers, facilitators, and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia.
    Hamilton M; Mathieson S; Gnjidic D; Jansen J; Weir K; Shaheed CA; Blyth F; Lin CC
    Pain; 2022 Apr; 163(4):e518-e526. PubMed ID: 33990105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain.
    Anderson TS; Wang BX; Lindenberg JH; Herzig SJ; Berens DM; Schonberg MA
    JAMA Netw Open; 2024 Mar; 7(3):e241342. PubMed ID: 38446478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study.
    AlRasheed MM; Alhawassi TM; Alanazi A; Aloudah N; Khurshid F; Alsultan M
    Clin Interv Aging; 2018; 13():1401-1408. PubMed ID: 30122912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid deprescribing: Qualitative perspectives from those with chronic non-cancer pain.
    Hamilton M; Gnjidic D; Christine Lin CW; Jansen J; Weir KR; Shaheed CA; Blyth F; Mathieson S
    Res Social Adm Pharm; 2022 Dec; 18(12):4083-4091. PubMed ID: 35963766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: protocol for a qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Bourne A; Maher C; Mathieson S; Lin CC; O'Connor DA
    BMJ Open; 2019 Nov; 9(11):e034039. PubMed ID: 31722956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
    BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis.
    Langford AV; Gnjidic D; Lin CC; Bero L; Penm J; Blyth FM; Schneider CR
    BMJ Qual Saf; 2021 Feb; 30(2):133-140. PubMed ID: 32220937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in Australian general practice settings: a qualitative study using the theory of Planned Behaviour.
    Wilson H; Roxas BH; Lintzeris N; Harris MF
    BMC Prim Care; 2024 Jul; 25(1):236. PubMed ID: 38961328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pragmatic Delphi study aimed at determining practical components for a tool designed to assist Dutch primary care-givers in opioid deprescribing for non-cancer pain.
    Jansen-Groot Koerkamp EAW; de Kleijn L; Fakhry R; Chiarotto A; Heringa M; Rijkels-Otters HJBM; Blom JW; Numans ME; Koes BW; Bouvy ML
    Fam Pract; 2023 Dec; 40(5-6):827-843. PubMed ID: 37237431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers, facilitators and needs to deprescribe benzodiazepines and other sedatives in older adults: a mixed methods study of primary care provider perspectives.
    Hürlimann O; Alers D; Hauri N; Leist P; Schneider C; Bolt L; Rodondi N; Aubert CE
    BMC Geriatr; 2024 May; 24(1):396. PubMed ID: 38704540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Views of medical practitioners about deprescribing in older adults: Findings from an Italian qualitative study.
    D'Avanzo B; Agosti P; Reeve E; Pasina L; Sabbà C; Mannucci PM; Nobili A
    Maturitas; 2020 Apr; 134():29-33. PubMed ID: 32143773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General practitioners' attitudes towards opioids for non-cancer pain: a qualitative systematic review.
    Punwasi R; de Kleijn L; Rijkels-Otters JBM; Veen M; Chiarotto A; Koes B
    BMJ Open; 2022 Feb; 12(2):e054945. PubMed ID: 35105588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' perspectives about the role of primary healthcare providers in long-term opioid therapy: a qualitative study in Dutch primary care.
    Davies LEM; Koerkamp EAJ; Koster ES; Dalusong KJ; Koch B; Schellekens AF; Heringa M; Bouvy ML
    Br J Gen Pract; 2024 Jul; 74(744):e475-e481. PubMed ID: 38499298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provider beliefs about the ideal design of an opioid deprescribing and substitution intervention for older adults.
    Margraf AM; Davoodi NM; Chen K; Shield RR; McAuliffe LM; Collins CM; Zullo AR
    Am J Health Syst Pharm; 2023 Jan; 80(2):53-60. PubMed ID: 36205419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Barriers and Facilitators to the Uptake of Best Practices for the Treatment of Co-Occurring Chronic Pain and Opioid Use Disorder.
    Varley AL; Lappan S; Jackson J; Goodin BR; Cherrington AL; Copes H; Hendricks PS
    J Dual Diagn; 2020; 16(2):239-249. PubMed ID: 31769729
    [No Abstract]   [Full Text] [Related]  

  • 18. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
    Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
    Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations.
    Langford AV; Lin CC; Bero L; Blyth FM; Doctor J; Holliday S; Jeon YH; Moullin J; Murnion B; Nielsen S; Osman R; Penm J; Reeve E; Reid S; Wale J; Schneider CR; Gnjidic D
    Med J Aust; 2023 Jul; 219(2):80-89. PubMed ID: 37356051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "The lesser of two evils": a framework analysis of consumers' perspectives on opioid deprescribing and the development of opioid deprescribing guidelines.
    Langford AV; Gnjidic D; Lin CC; Bero L; Blyth F; Penm J; Schneider CR
    Pain; 2021 Nov; 162(11):2686-2692. PubMed ID: 33769364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.